BSc (Health Sciences), PhD
Ruth Thomas joined the Unit in 1993 as a research assistant. She completed her PhD in the Unit in 2002 and went on to take up a Wellcome Trust Training Fellowship in Health Services Research which she completed in 2006. Ruth is a Health Services Researcher experienced in a range of HSR methods including systematic reviews, overviews, RCTs (simple and complex), and other evaluative designs. Ruth worked on a series of "knowledge translation" evaluations ie getting evidence into clinical practice, involving complex rigorous designs. She is currently the Research Manager for the Centre Healthcare Randomised Trials (CHaRT) a fully registered UK Clinical Research Collaboration Clinical Trials Unit with an internationally recognised expertise in the design, conduct, analysis and reporting of multicentre trials. .
- Centre for Healthcare Randomised Trials (CHaRT)
- Scottish Collaboration of Trialists (SCoT)
- Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of calcium channel blockers (nifedipine) and alpha blockers (tamsulosin) - (SUSPEND)
- Therapeutic Interventions for Stones of the Ureter (TISU)
- The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer
- Diagnostic request advisory model: the rationalisation of laboratory test ordering in general practice (DRAM)
- Establishing a scientific rationale for choosing interventions to translate research findings into clinical practice: The PR1ME project
- The accuracy of accredited glaucoma optometrists in the diagnosis and treatment recommendation for glaucoma
- A systematic review of the effectiveness and efficiency of guideline dissemination and implementation strategies
- Cochrane Effective Practice and Organisation of Care (EPOC) Review Group
Chief Scientists Office of the Scottish Government CZH/4/945 – Multiple Symptoms Study 2. A feasibility study to manualise, teach and demonstrate the delivery of the Symptoms Clinic intervention £139,962 Start date: April 2014 - 12 month
NIHR HTA (10/137/01). Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones. Funder: Value: £1,426,755.Start date: 1st March 2013 - 48 months
NIHR HTA (08/71/01) SUSPEND: Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multi centre placebo randomised trial. Start date: Value: £1,585,180 (+ 132,732). 1st June 2010 - 42 months extended to 53 months.
The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer. Funder: NIHR HTA (07/47/01). Start date: 1st June 2008. Value: £239,474.